Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 23498 [2016-09269]

Download as PDF jstallworth on DSK7TPTVN1PROD with NOTICES 23498 Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices reasonable likelihood that such radiation doses may have endangered the health of members of this class. SPR was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. SPR is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU). Matters for Discussion: The agenda for the Subcommittee meeting includes: Discussion of procedures in the following ORAU and DCAS technical documents: OCAS Technical Information Bulletin (TIB) 0014 (‘‘Rocky Flats Internal Dosimetry Coworker Extension’’), ORAU OTIB 0013 (‘‘Individual Dose Adjustment Procedures for Y–12 Dose Reconstructions’’), ORAU OTIB 0029 (‘‘Internal Dose Reconstructions for Y– 12’’), ORAU OTIB 0039 (‘‘Internal Dose Reconstructions for Hanford’’), ORAU OTIB 0050 (‘‘The Use of Rocky Flats Neutron Dose Reconstruction Project Data in Dose Reconstructions’’), ORAU OTIB 0060 (‘‘Internal Dose Reconstructions’’), Program Evaluation Report (PER) 003 (‘‘The Effects of Adding Ingestion Intakes to Bethlehem Steel Cases’’), PER 004 (‘‘Application of Photofluorography at the Pinellas Plant’’), PER 005 (‘‘Misinterpreted Application of External Dose Factor for Hanford Dose Reconstructions’’), PER 029 (‘‘Hanford TBD Revision’’), PER 042 (‘‘Linde Ceramic Plant TBD Revision’’), PER 045 (‘‘Aliquippa Forge TBD Revision’’), ORAU PROC 0042 (‘‘Incomplete Monitoring at Y–12’’), ORAU RPRT 0044 (‘‘Analysis of Bioassay Data with Significant Fraction of Less-Than Results’’); and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. Contact Person For More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30329–4027, Telephone (513) 533–6800, Toll Free 1(800) CDC–INFO, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Sep<11>2014 13:27 Apr 20, 2016 Jkt 238001 Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2016–09268 Filed 4–20–16; 8:45 am] Agency Forms Undergoing Paperwork Reduction Act Review BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns the CDC National Centers for Excellence in Youth Violence Prevention: Operations Research (Implementation Science) for Strengthening Program Implementation through the President’s Emergency Plan for AIDS Relief (PEPFAR), RFA–GH–16– 005, initial review. This publication corrects a notice that was published in the Federal Register on March 22, 2016 Volume 81, Number 55, pages 15307. The meeting place should read as follows: SUMMARY: DATES: Times and Dates: 9:00 a.m.–2:00 p.m., EDT, Panel A, April 26, 2016 (Closed) 9:00 a.m.–2:00 p.m., EDT, Panel B, April 27, 2016 (Closed) FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone: (404) 639–4796, HMS4@CDC.GOV. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016–09269 Filed 4–20–16; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 [30Day–16–1061] The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Behavioral Risk Factor Surveillance System (BRFSS) (OMB Control No. 0920–1061, exp. 3/31/2018)— Revision—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)—Centers for Disease Control and Prevention (CDC). E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 81, Number 77 (Thursday, April 21, 2016)]
[Notices]
[Page 23498]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09269]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns the CDC National Centers for 
Excellence in Youth Violence Prevention: Operations Research 
(Implementation Science) for Strengthening Program Implementation 
through the President's Emergency Plan for AIDS Relief (PEPFAR), RFA-
GH-16-005, initial review.

SUMMARY: This publication corrects a notice that was published in the 
Federal Register on March 22, 2016 Volume 81, Number 55, pages 15307. 
The meeting place should read as follows:

DATES: Times and Dates:

9:00 a.m.-2:00 p.m., EDT, Panel A, April 26, 2016 (Closed)
9:00 a.m.-2:00 p.m., EDT, Panel B, April 27, 2016 (Closed)

FOR FURTHER INFORMATION CONTACT: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796, HMS4@CDC.GOV.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2016-09269 Filed 4-20-16; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.